Renalytix (LSE:RENX) Short-Term Capital Lease Obligation : £0.06 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Renalytix Short-Term Capital Lease Obligation?

Renalytix's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was £0.06 Mil.

Renalytix's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 (£0.11 Mil) to Dec. 2023 (£0.09 Mil) and declined from Dec. 2023 (£0.09 Mil) to Mar. 2024 (£0.06 Mil).

Renalytix's annual Short-Term Capital Lease Obligation declined from Jun. 2021 (£0.06 Mil) to Jun. 2022 (£0.00 Mil) but then increased from Jun. 2022 (£0.00 Mil) to Jun. 2023 (£0.10 Mil).

Renalytix Short-Term Capital Lease Obligation Historical Data

The historical data trend for Renalytix's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Short-Term Capital Lease Obligation Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.07

0.06

0.10

Renalytix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.11	0.10	0.11	0.09	0.06

Renalytix Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Renalytix Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Renalytix's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix (LSE:RENX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

RNLX:USA RTNXF:USA 2O9:Germany

Address

5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe • 08-29-2013

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex • 12-14-2012

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

By PRNewswire PRNewswire • 03-27-2018

Investing in Information

By Vanina Egea Vanina Egea • 03-06-2014